Acute Psychosis |
- Delusions, hallucinations, disorganised thinking, and behavioural disturbances.
- Agitation, aggression, and inability to engage in reality-based conversation.
- May be caused by schizophrenia, bipolar disorder, severe depression, or substance misuse.
|
- Clinical assessment, including mental state examination (MSE).
- Toxicology screen to rule out substance misuse.
- Blood tests (e.g., FBC, U&Es, LFTs) to exclude metabolic causes or side effects of medication.
- CT or MRI brain scan if organic causes are suspected (e.g., head injury, tumour).
|
- Administration of antipsychotic medication (e.g., haloperidol, olanzapine).
- Consider benzodiazepines (e.g., lorazepam) for sedation if agitation is severe.
- Admit to a psychiatric unit for further assessment and management.
- Consider use of the Mental Health Act if the patient lacks capacity and poses a risk to themselves or others.
|
Suicidal Ideation or Attempt |
- Expressed intent to harm or kill oneself, or recent suicide attempt.
- May present with low mood, hopelessness, withdrawal from social activities, and self-harm.
- Common in severe depression, bipolar disorder, personality disorders, and after traumatic events.
|
- Comprehensive psychiatric assessment, including risk assessment for suicide.
- Physical examination to identify injuries or signs of self-harm.
- Blood tests and toxicology screen if overdose or poisoning is suspected.
- Consider referral for urgent psychological or psychiatric evaluation.
|
- Immediate safety measures, such as constant observation and removal of potential means of harm.
- Admission to hospital (psychiatric or general) depending on severity and risk assessment.
- Initiate antidepressant treatment if clinically indicated and provide psychological support.
- Crisis intervention and referral to community mental health services for ongoing support.
|
Acute Mania |
- Elevated or irritable mood, increased energy, decreased need for sleep, and impulsive behaviour.
- Grandiosity, racing thoughts, pressured speech, and poor judgement.
- May be associated with bipolar disorder, substance misuse, or other psychiatric conditions.
|
- Clinical assessment, including mental state examination (MSE).
- Toxicology screen to rule out substance-induced mania.
- Blood tests (e.g., thyroid function tests) to rule out metabolic causes.
- Consider ECG if treatment with lithium or antipsychotics is planned.
|
- Initiate treatment with mood stabilisers (e.g., lithium, valproate) or antipsychotics (e.g., olanzapine).
- Benzodiazepines (e.g., lorazepam) for short-term sedation and management of agitation.
- Admit to a psychiatric unit for stabilisation and monitoring.
- Consider use of the Mental Health Act if the patient lacks capacity and poses a risk to themselves or others.
|
Neuroleptic Malignant Syndrome (NMS) |
- Hyperthermia, muscle rigidity, altered mental status, and autonomic instability (e.g., tachycardia, labile blood pressure).
- Associated with the use of antipsychotic medications, particularly high-potency neuroleptics.
- Symptoms may develop over hours to days, and the condition can be life-threatening.
|
- Clinical diagnosis based on presentation and history of antipsychotic use.
- Blood tests showing elevated creatine kinase (CK), leukocytosis, and renal impairment.
- Consider CT or MRI if there is suspicion of an alternative neurological cause.
|
- Immediate discontinuation of the offending antipsychotic medication.
- Supportive care, including IV fluids, cooling measures, and management of complications (e.g., renal failure).
- Consider the use of dantrolene, bromocriptine, or amantadine in severe cases.
- Admit to an ICU for close monitoring if the condition is severe.
|
Serotonin Syndrome |
- Agitation, confusion, myoclonus, hyperreflexia, and autonomic instability (e.g., tachycardia, hyperthermia).
- May also present with tremor, diarrhoea, and sweating.
- Often occurs after initiation or overdose of serotonergic drugs (e.g., SSRIs, MAOIs, MDMA).
|
- Clinical diagnosis based on presentation and history of serotonergic drug use.
- No specific diagnostic tests, but blood tests may show elevated CK and metabolic acidosis.
- Consider ECG to monitor for arrhythmias.
|
- Immediate discontinuation of serotonergic drugs.
- Supportive care, including IV fluids, benzodiazepines for agitation, and cooling measures for hyperthermia.
- Consider administration of cyproheptadine, a serotonin antagonist, in moderate to severe cases.
- Admission to ICU for severe cases with close monitoring of vital signs and complications.
|
Alcohol Withdrawal Delirium (Delirium Tremens) |
- Agitation, confusion, hallucinations, tremors, and autonomic instability (e.g., tachycardia, hypertension, hyperthermia).
- Occurs typically 48-72 hours after the last alcohol intake in dependent individuals.
- Risk factors include a history of heavy alcohol use, previous withdrawal seizures, and concurrent medical illness.
|
- Clinical diagnosis based on history and presentation.
- Blood tests including electrolytes, magnesium, and liver function tests to identify and correct abnormalities.
- ECG to monitor for arrhythmias.
|
- Benzodiazepines (e.g., diazepam, lorazepam) are the mainstay of treatment for symptom control.
- Thiamine supplementation to prevent Wernicke’s encephalopathy.
- IV fluids and correction of electrolyte imbalances.
- Admission to a medical ward or ICU for close monitoring and management of complications.
|
Violent or Aggressive Behaviour |
- Physical aggression, verbal threats, and agitation, posing a risk to self or others.
- May be associated with acute psychosis, substance misuse, personality disorders, or delirium.
- Often exacerbated by environmental stressors or failure to adhere to medication.
|
- Clinical assessment focusing on the cause of the aggression.
- Toxicology screen to rule out substance misuse.
- Blood tests to identify metabolic or neurological contributors to behaviour.
|
- De-escalation techniques, including verbal calming and creating a safe environment.
- Administration of rapid tranquilisation (e.g., intramuscular lorazepam, haloperidol) if necessary.
- Use of the Mental Health Act for involuntary treatment if the patient lacks capacity and poses a risk.
- Admission to a secure psychiatric unit for ongoing management and assessment.
|